MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
Discover the top 3 undervalued Automobile Components stocks for Friday, December 26 based on AAII’s Stock Grades.
The M2 Max and Ultra Mac Studio were released back in 2023 at WWDC. The company then completely bypassed the M3 generation and, even with the advent of the M4 era in 2024, made no moves to update the ...
JANUARY Wildfires Devastate Los Angeles Devastating wildfires swept through Altadena and Pacific Palisades – the worst natural disaster Los Angeles has ...
The former selector said that bringing Shubman Gill back into T20Is on the back of his England Test heroics was a “wrong move” in the first place. Shubman Gill was not picked in the India T20 World ...
Ashwin expanded on the technical flaws he sees in several top overseas batters while facing spin, using Ben Stokes and others as examples. Ben Stokes reacts after being bowled by Nathan Lyon in the ...
MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback